ECO Animal Health has delivered another set of remarkably solid FY results, in line with expectations in spite of challenging market conditions in the US and the nationwide ASF outbreak in China. Aivlosin® maintained its impressive growth trajectory during the period (+14% YoY), demonstrating yet again the strength of the brand and the economic advantage vs. competing products in swine & poultry markets. Overall margins were in line with expectations, with increased external development expendit ....
19 Jun 2019
In-line results demonstrate resilience and solid growth
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
In-line results demonstrate resilience and solid growth
ECO Animal Health Group plc (EAH:LON) | 94.0 0 0.0% | Mkt Cap: 63.7m
- Published:
19 Jun 2019 -
Author:
Jens Lindqvist -
Pages:
4
ECO Animal Health has delivered another set of remarkably solid FY results, in line with expectations in spite of challenging market conditions in the US and the nationwide ASF outbreak in China. Aivlosin® maintained its impressive growth trajectory during the period (+14% YoY), demonstrating yet again the strength of the brand and the economic advantage vs. competing products in swine & poultry markets. Overall margins were in line with expectations, with increased external development expendit ....